Stealth BioTherapeutics Corp. ADS
MITO
MITO was delisted on the 15th of November, 2022.
7 hedge funds and large institutions have $3.11M invested in Stealth BioTherapeutics Corp. ADS in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0% more funds holding
Funds holding: 7 → 7 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
21% less capital invested
Capital invested by funds: $3.91M → $3.11M (-$804K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$115K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$27K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.88K |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$161 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DIM
DC Investments Management
Mclean,
Virginia
|
-$646K |
| 2 |
Millennium Management
New York
|
-$216K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KCM
1
Kingdon Capital Management
New York
| $2.23M | – | – | – |
|
|
2
Millennium Management
New York
| $434K | -$216K | -16,124 | -31% |
|
|
3
Bank of America
Charlotte,
North Carolina
| $410K | +$115K | +8,604 | +36% |
|
|
4
UBS Group
Zurich,
Switzerland
| $26K | +$27K | +2,016 | +3,102% |
|
|
CCA
5
Catalyst Capital Advisors
Huntington,
New York
| $7K | – | – | – |
|
|
6
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $2K | +$2.88K | +215 | New |
|
|
DIM
7
DC Investments Management
Mclean,
Virginia
| – | -$646K | -50,420 | Closed |
|
|
8
Bank of Montreal
Toronto,
Ontario, Canada
| – | +$161 | +12 | +400% |
|
MITO Hedge Fund Activity: Q2 2019 in Review
7 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Stealth BioTherapeutics Corp. ADS (MITO) for Q2 2019, worth a combined $3.11M — down 21% from $3.91M a quarter earlier.
Fund positioning in MITO was balanced in Q2 2019: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 1 trimmed.
The largest buyer was Bank of America, adding an estimated $115K. The largest seller was DC Investments Management, exiting entirely with an estimated $646K sold.
- 7 institutional investors held Stealth BioTherapeutics Corp. ADS (MITO) as of Q2 2019, unchanged from Q1 2019.
- Funds reported $3.11M of Stealth BioTherapeutics Corp. ADS stock for Q2 2019, down 21% quarter-over-quarter.
- 1 fund opened new Stealth BioTherapeutics Corp. ADS positions in Q2 2019 and 1 closed out, a net change of 0 holders.
- The largest Stealth BioTherapeutics Corp. ADS buyer in Q2 2019 was Bank of America, an estimated $115K added.
- The largest Stealth BioTherapeutics Corp. ADS seller in Q2 2019 was DC Investments Management, an estimated $646K sold.
Based on aggregated 13F filings for Q2 2019.